Antibiotice Ia Cash Flow Quality Index

Latest as of June 2026: 6.40x

Antibiotice Ia cash flow quality index. Antibiotice Ia (ATB) has a Cash Flow Quality Index of 6.40x as of June 2026. Operating cash flow of RON18.71 Million exceeds net income of RON2.92 Million, indicating high earnings quality where cash backs reported profits. See ATB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

6.40x
Operating CF / Net Income

Operating Cash Flow

RON18.71 Million
RON

Net Income

RON2.92 Million
RON

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of Antibiotice Ia (2022–2025)

Cash flow quality index of Antibiotice Ia from 2022 to 2025. Historical Cash Flow Quality Index for Antibiotice Ia across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ATB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Antibiotice Ia Cash Flow Quality Index by Year (2022–2025)

Antibiotice Ia cash flow quality index by year from 2022 to 2025. Year-by-year earnings quality comparison for Antibiotice Ia. For the full cash flow conversion analysis, see Antibiotice Ia cash flow conversion.

Year Quality Index Operating CF (RON) Net Income YoY Change
2025 1.40x RON72.44 Million RON51.77 Million ▲ +46.2%
2024 0.96x RON95.15 Million RON99.42 Million ▼ -36.6%
2023 1.51x RON122.46 Million RON81.09 Million ▼ -49.7%
2022 3.00x RON115.66 Million RON38.51 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.